Top compounds associated with response to LGALS9B


Feature Type Standardized
Nominal ANOVA
mRNA BEC CTRPv2 pan-cancer AAC 0.024 0.8
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.011 0.8
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.011 0.8
mRNA ifosfamide CTRPv2 pan-cancer AAC -0.016 0.8
mRNA Fumonisin B1 CTRPv2 pan-cancer AAC 0.011 0.8
mRNA itraconazole CTRPv2 pan-cancer AAC -0.011 0.8
mRNA momelotinib CTRPv2 pan-cancer AAC -0.01 0.8
mRNA AC55649 CTRPv2 pan-cancer AAC -0.011 0.8
mRNA BRD-K85133207 CTRPv2 pan-cancer AAC -0.011 0.8
mRNA narciclasine CTRPv2 pan-cancer AAC 0.0092 0.8
Download CSV